NCT00539370

Brief Summary

This protocol will enable IRB (institutional review board) review of proposed research using human samples and data collected under the terminated NIH studies 04-EI-0065 and 96-EI-0096. Data and samples may include demographic and personal health information, psychological or psychiatric testing, blood, urine, CSF or other body fluids or tissues and results of medical and physiological evaluation and medical imaging. Data and sample analyses are limited to those approved under the original protocols unless additional specific institutional review board approval is obtained.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,862

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 29, 2007

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 3, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 4, 2007

Completed
13.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 6, 2021

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 19, 2022

Completed
Last Updated

August 26, 2022

Status Verified

August 1, 2022

Enrollment Period

13.7 years

First QC Date

October 3, 2007

Last Update Submit

August 25, 2022

Conditions

Keywords

ScleritisIntermediate UveitisPosterior UveitisIntraocular Inflammatory DiseaseData AnalysisData CollectionSample Analysis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants who were followed in terminated branch protocols under which data or samples were collected.

* Data Analysis Study

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Blood, DNA, and pharmacokinetic samples have been retained

MeSH Terms

Conditions

UveitisScleritisUveitis, IntermediateUveitis, Posterior

Condition Hierarchy (Ancestors)

Uveal DiseasesEye DiseasesScleral DiseasesPanuveitis

Study Officials

  • Hatice N Sen, M.D.

    National Eye Institute (NEI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 3, 2007

First Posted

October 4, 2007

Study Start

August 29, 2007

Primary Completion

May 6, 2021

Study Completion

August 19, 2022

Last Updated

August 26, 2022

Record last verified: 2022-08

Locations